ANTX
AN2 Therapeutics Inc
4.70$
-3.5%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 82.2% | 79.6% | 95.9% | 99.0% | 100.0% | 93.7% | 85.5% | 89.1% | 95.2% | 96.8% | 100.0% | 97.9% | |
| 21.2% | 11.3% | 20.4% | 24.7% | 34.3% | 23.2% | 24.6% | 24.0% | 26.8% | 32.2% | 61.1% | 54.3% | |
| 80.5% | 77.3% | 94.2% | 96.4% | 95.6% | 90.8% | 82.4% | 83.0% | 92.1% | 93.6% | 97.5% | 96.0% | |
| – | 1.0% | 0.4% | 0.3% | 1.0% | 0.3% | 0.4% | 3.6% | 0.6% | 1.5% | 0.3% | 0.4% | |
| 9.6% | 10.1% | 8.8% | 9.3% | 10.3% | 11.1% | 9.9% | 9.2% | 10.2% | 14.4% | 6.6% | 7.0% | |
| 9.6% | 10.1% | 8.8% | 9.3% | 10.3% | 11.1% | 9.9% | 2.8% | 10.2% | 14.1% | 6.4% | 6.8% | |
| 3.2% | 1.9% | 2.0% | 1.7% | 1.8% | 3.6% | 3.8% | 2.8% | 3.3% | 4.9% | 3.0% | 2.4% | |
| 90.4% | 89.9% | 91.2% | 90.7% | 89.7% | 88.9% | 90.1% | 90.8% | 89.8% | 85.6% | 93.4% | 93.0% | |
| -89.4% | -111.3% | -141.1% | -171.0% | -202.9% | -223.5% | -266.1% | -293.9% | -345.4% | -388.9% | -286.9% | -317.3% | |
| 16.7% | 21.4% | 24.5% | 27.5% | 30.5% | 32.5% | 36.9% | 39.8% | 45.0% | 48.8% | 38.9% | 54.8% |
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.